Hemogenyx Pharmaceuticals Plc

About

706.00GBX+16.00 +2.32%
Live at 21:41 GMT+00:00
Market Cap$63.34M
Volume16.1K
Beta-1.61
RSI44.52
Health TechnologyBiotechnology

Hemogenyx Pharmaceuticals Plc — investor relations, events, news, and company updates on 6ix.

Recent Videos

Inside Hemogenyx’s Long Term Vision Trials, Partnerships, and Early Revenue
Inside Hemogenyx’s Long Term Vision Trials, Partnerships, and Early Revenue
Nov 15, 2025
Hemogenyx Advances CAR-T Therapy: Green Light for Next Trial Phase
Hemogenyx Advances CAR-T Therapy: Green Light for Next Trial Phase
Nov 06, 2025
Hemogenyx CEO on positive progress with leukemia drug
Hemogenyx CEO on positive progress with leukemia drug
Oct 30, 2025
Vladislav Sandler, CEO Hemogenyx Pharma, on funding, burn-rate cuts & pipeline beyond CAR-T.
Vladislav Sandler, CEO Hemogenyx Pharma, on funding, burn-rate cuts & pipeline beyond CAR-T.
Sep 26, 2025

Community Chat

Ask AI

Try asking